Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
1.
2.
Novartis to Buy Biotech Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
Today's top topics:
google
anthropic
apple
android authority
iphone
zdnet
openai
android 17
android
claude